The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
